| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |